HMGB1P46: A Drug Target / Disease Biomarker (G100419978)

Target Name: HMGB1P46

NCBI ID: G100419978

HMGB1P46

Other Name(s): high mobility group box 1 pseudogene 46 | High mobility group box 1 pseudogene 46

HMGB1P46: A Drug Target / Disease Biomarker

HMGB1P46 is a protein that is expressed in various tissues throughout the body, including the liver, muscle, and heart. It is a key regulator of cellular processes that are involved in the development and maintenance of tissues, including the regulation of cell growth, apoptosis, and inflammation.

Recent studies have identified HMGB1P46 as a potential drug target or biomarker for a variety of diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. This is because the protein is involved in many cellular processes that are associated with the development and progression of these diseases, and because it has been shown to play a role in the regulation of cellular processes that are important in disease development.

One of the key functions of HMGB1P46 is its role in the regulation of cell growth and apoptosis. This is important because changes in cellular growth and apoptosis are involved in the development and progression of many diseases, including cancer. For example, altered levels of apoptosis have been observed in many types of cancer, and studies have shown that inhibiting apoptosis has the potential to be a effective way to treat these diseases.

Another function of HMGB1P46 is its role in the regulation of inflammation. This is important because chronic inflammation is associated with many diseases, including cardiovascular disease and neurodegenerative disorders. For example, studies have shown that reducing inflammation can improve the progression of neurodegenerative disorders, such as Alzheimer's disease.

In addition to its role in cell growth and apoptosis, HMGB1P46 is also involved in the regulation of many other cellular processes that are important in disease development. For example, the protein has been shown to play a role in the regulation of cell migration, and changes in cell migration are involved in the development of many diseases, including cancer.

Furthermore, HMGB1P46 is also involved in the regulation of the immune system. This is important because changes in the immune system have been observed in many diseases, including cancer and neurodegenerative disorders. For example, studies have shown that disrupting the immune response has the potential to promote the growth and progression of cancer cells.

In conclusion, HMGB1P46 is a protein that is involved in many cellular processes that are important in disease development. As a result, it has been identified as a potential drug target or biomarker for a variety of diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. Further research is needed to fully understand the role of HMGB1P46 in these diseases and to develop effective treatments.

Protein Name: High Mobility Group Box 1 Pseudogene 46

The "HMGB1P46 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HMGB1P46 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets